{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:27:31Z","timestamp":1786681651293,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jss.2026.03.045","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T10:42:31Z","timestamp":1775385751000},"page":"508-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Renin-Angiotensin-Aldosterone Medication Use and Outcomes in Injured Patients Receiving Blood"],"prefix":"10.1016","volume":"321","author":[{"given":"Hope E.","family":"Werenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra I.","family":"Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jason","family":"Hoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Stettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2026.03.045_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2026.03.045_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/SLA.0b013e3181d3599c","article-title":"Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography","volume":"251","author":"Kashuk","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2026.03.045_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/SLA.0000000000000837","article-title":"Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium","volume":"261","author":"Tisherman","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2026.03.045_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-021-03816-x","article-title":"Why the renin\u2013angiotensin\u2013aldosterone system (RAAS) in critically ill patients can no longer be ignored","volume":"25","author":"Zarbock","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jss.2026.03.045_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-024-05123-7","article-title":"The renin\u2013angiotensin\u2013aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II","volume":"28","author":"Legrand","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.jss.2026.03.045_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171201","article-title":"Dysfunction of the renin-angiotensin-aldosterone system in human septic shock","volume":"176","author":"Schaich","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.jss.2026.03.045_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jss.2026.03.045_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jss.2026.03.045_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajem.2022.10.006","article-title":"Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis","volume":"62","author":"Hasegawa","year":"2022","journal-title":"The Am J Emerg Med"},{"key":"10.1016\/j.jss.2026.03.045_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/HYPERTENSIONAHA.119.13197","article-title":"Effect of renin-angiotensin-aldosterone System inhibitors on short-term mortality after sepsis: a population-based cohort Study","volume":"75","author":"Hsu","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jss.2026.03.045_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-024-04910-6","article-title":"ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock","volume":"28","author":"Leisman","year":"2024","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jss.2026.03.045_bib20","first-page":"1","volume":"2","year":"2012","journal-title":"Kidney Int Supplements"},{"key":"10.1016\/j.jss.2026.03.045_bib27","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s11135-017-0584-6","article-title":"Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour","volume":"52","author":"Johnston","year":"2018","journal-title":"Qual Quant"},{"key":"10.1016\/j.jss.2026.03.045_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1060028017726552","article-title":"Effects of chronic antihypertensives on vasopressor dosing in septic shock","volume":"52","author":"DeMott","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jss.2026.03.045_bib13","first-page":"305","article-title":"Resuscitation with fresh whole blood ameliorates the inflammatory response after hemorrhagic shock","volume":"68","author":"Makley","year":"2010","journal-title":"J Trauma"},{"key":"10.1016\/j.jss.2026.03.045_bib14","article-title":"Controlled hemorrhage sensitizes angiotensin II-Elicited hypertension through activation of the brain renin-angiotensin System independently of endoplasmic reticulum stress","volume":"2022","author":"Wu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jss.2026.03.045_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40256-013-0058-8","article-title":"Differences in the clinical effects of angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers: a critical review of the evidence","volume":"14","author":"Dezsi","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jss.2026.03.045_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12028-019-00755-y","article-title":"Association of angiotensin-converting enzyme inhibitors with increased mortality among patients with isolated severe traumatic brain injury","volume":"31","author":"Catapano","year":"2019","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jss.2026.03.045_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1009757416302","article-title":"Role of angiotensin II in coagulation and fibrinolysis","volume":"3","author":"Brown","year":"1999","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jss.2026.03.045_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00220-22","article-title":"Repressed ang 1-7 in COVID-19 is inversely associated with inflammation and coagulation","volume":"7","author":"Carpenter","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.jss.2026.03.045_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2119\/2007-00073.Fraga-Silva","article-title":"The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets","volume":"14","author":"Fraga-Silva","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.jss.2026.03.045_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00001721-200011010-00007","article-title":"Platelet activation during angiotensin II infusion in healthy volunteers","volume":"11","author":"Larsson","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jss.2026.03.045_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/micc.12120","article-title":"Roles of coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis","volume":"21","author":"Senchenkova","year":"2014","journal-title":"Microcirculation"},{"key":"10.1016\/j.jss.2026.03.045_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/CCM.0000000000006095","article-title":"Association of active renin content with mortality in critically ill patients: a post hoc analysis of the vitamin C, thiamine, and steroids in sepsis (VICTAS) trial","volume":"52","author":"Busse","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jss.2026.03.045_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/jcm10030412","article-title":"Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on acute kidney injury in emergency medical admissions","volume":"10","author":"Feidakis","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jss.2026.03.045_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.kint.2016.11.019","article-title":"Acute changes in glomerular filtration rate with renin-angiotensin system (RAS) inhibition: clinical implications","volume":"91","author":"Weir","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jss.2026.03.045_bib24","article-title":"The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: an observational study using the MIMIC database","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:38:03Z","timestamp":1786678683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480426001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"alternative-id":["S0022480426001484"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2026.03.045","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin-Angiotensin-Aldosterone Medication Use and Outcomes in Injured Patients Receiving Blood","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2026.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}